A study of intraperitoneal (i.p.)injection of pan-ErbB/IL-4 CAR T cells targeting patient-derived malignant pleural mesotheliomas xenografts in SCID mice showed tumor regression or cure in all mice [50]. The gene discussed is IL4; the disease is malignant pleural mesothelioma.